Clinical trial
Acute Changes in Intraocular Cytokines After Intravitreal Bevacizumab
NCT01439178 is registered in ClinicalTrials.gov with Seoul St. Mary's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Acute Changes in Intraocular Cytokines After Intravitreal Bevacizumab
- Lead sponsor
- Seoul St. Mary's Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 31, 2011
- Completion date
- November 30, 2011
- Enrollment
- 28 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
complications of diabetes mellitus